协同催化——溶剂萃取光率法测定血清中的唾液酸

利用Cu^2 和Cr^3 的协同催化作用,促进间苯二酚与唾液酸的显色,再用乙酸丁酯——正丁醇萃取有色物质,变换波长至625nm处测定;血清中的唾液酸含量。建立了血清中唾液酸测定的新方法,方法的线性范围为0－1000mg/L,检出限为2.1mg/L,相对标准偏差为1.59%-2.11%,回收率为96.2%-101.2%,糖类及抗坏血酸等物质对测定的干扰＜2％。该法简单、快速、灵敏、准确,可用于临床体液中唾液酸的测定。     

液相色谱-质谱法对奶粉中唾液酸含量的测定

唾液酸是一种天然大脑营养素,能促进婴儿的智力发育,增加记忆力[1].本文建立了利用液相色谱一质谱联用(LC-MS/MS)技术测定奶粉中唾液酸含量的分析方法.方法在0.1～100 mg/L之间有很好的线性关系,检出限为0.06 mg/L,相对标准偏差小于10%.该方法准确、简单、灵敏度高,可广泛应用于奶粉、牛奶及母乳中唾液酸的含量测定.     

超高效液相色谱-串联四极杆质谱法分析婴儿乳粉中的唾液酸

建立了超高效液相色谱-串联质谱(UPLC-MS/MS)测定婴儿配方乳粉中唾液酸含量的分析方法。利用酸水解方法释放出婴儿配方乳中的唾液酸,经HLB反相色谱固相萃取柱净化,采用BEH HILIC色谱柱分离,以0.1%甲酸水溶液和100%乙腈溶液作为流动相进行梯度洗脱,流速为0.25 mL/min,进样体积5 μL,柱温30℃,电喷雾质谱检测,正离子多反应监测模式进行定性和定量分析。结果表明:唾液酸在0.05~5.0 mg/L范围内与唾液酸峰面积的线性关系良好(R²=0.9989);以0.1、0.5、2.5和5.0 mg/L 4个添加水平进行添加回收试验,唾液酸的平均回收率为84.3%~98.9%,相对标准偏差为4.9%~8.2%;唾液酸的检出限为0.01 mg/L。该方法简单、快速、重复性好、灵敏度高,可广泛用于奶粉、牛奶及母乳中唾液酸含量的分析测定。     

荧光探针碘苷在血清白蛋白同步荧光测定中的应用研究

在最佳实验条件下,碘苷与血清白蛋白相互作用,导致血清白蛋白的内源荧光发生特异性变化,且体系的同步荧光强度和溶液中血清白蛋白的浓度呈线性关系.据此,建立了以碘苷为荧光探针,运用固定波长同步荧光光谱分析测定人血清白蛋白和牛血清白蛋白的新方法.体系的同步荧光强度与人血清白蛋白和牛血清白蛋白分别在1.38～579 mg/L和0.78～585 mg/L范围内呈良好的线性关系,检出限分别为0.612 mg/L和0.358 mg/L.对实际样品进行回收测定,回收率为97%～101%.     

奶粉中唾液酸的测定方法

利用酸水解把奶粉中的唾液酸释放出来，通过聚丙烯酰胺凝胶除去奶粉中大量乳糖的干扰。利用Cu^2＋和Cr^3＋协同催化唾液酸与间苯二酚的显色，用乙酸丁酯-正丁醇萃取有色物质，在610nm处测定牛奶中唾液酸含量。方法的线性范围0～55．90mg／L，回收率为94％～96％。     

毛细管电泳-间接紫外法检测蜂蜜中的多种金属离子

探讨了一种利用毛细管电泳测定K+、Ba2+、Ca2+、Na+、Mg2+、Fe2+、Zn2+、Cd2+、Li+和Cu2+10种金属离子的方法。考察了紫外生色剂的浓度和pH值对分离效果的影响,并优化了分离条件。结果表明,咪唑浓度为15 mmol/L(pH 3.7),分离电压为20kV时,10种金属离子可在7min内实现基线分离。10种金属离子的线性范围为0.06～60.0mg/L,相关系数为0.9995～0.9999,检出限为0.01～0.21mg/L。标准样品的回收率为95%～104%,5次测定的相对标准偏差为0.9%～5.8%。将该法用于6个蜂蜜样品的测定,结果满意。     

蛋白质-四羧基铜酞菁体系的共振散射行为及其分析应用

在pH 3.0的Clark-Lub's 缓冲溶液中,蛋白质与四羧基铜酞菁(CuPc(COOH)4)作用,使体系的共振光散射增强,在λ=389 nm处光散射强度最大.增强作用的强弱与蛋白质的含量成正比,据此建立了共振光散射测定蛋白质的新方法.此方法对牛血清白蛋白(BSA)、人血清白蛋白(HSA)、免疫球蛋白G(IgG)、鱼精蛋白(Protamine)、血清总蛋白(TP)的测定范围分别为0.05～1.60 mg/L、 0.025～1.60 mg/L、 0～1.45 mg/L、 0.1～1.50 mg/L、 0～1.60 mg/L,相应检出限分别为1.12×10-2 mg/L、 1.11×10-2 mg/L、 1.95×10-2 mg/L、 3.61×10-3 mg/L、 4.34×10-3 mg/L.方法应用于实际人血清样品中总蛋白的测定,结果与考马斯亮蓝法基本一致.     

钒酸铵氧化-分光光度法测定盐酸氯丙嗪

在磷酸介质中,钒酸铵与盐酸氯丙嗪反应生成红色氧化产物,其最大吸收波长为524nm;据此建立了测定盐酸氯丙嗪含量的钒酸铵氧化-分光光度法,并将其用于直接测定药物制剂中的盐酸氯丙嗪.结果表明,当盐酸氯丙嗪的浓度处于10.0～100mg/L和100～360mg/L范围内时,被测定体系的吸光度与盐酸氯丙嗪的浓度之间呈良好的线性关系;线性回归方程分别为A=-0.061 69+0.010 05c(mg/L,r=0.998 8)、A=0.494+0.004 43c(mg/L,r=0.998 8),检出限为1.96mg/L,相对标准偏差为0.29%,回收率为94.9%～102.9%.     

离子色谱法测定中药女贞子浸煮液中的碱金属和碱土金属

用离子色谱法测定了中药女贞子水浸煮液中K+、Na+、Ca2+、Mg2+的含量,色谱柱为IonPAC CS 12A(4 mm×250 mm)阳离子交换柱,淋洗液为11.0 mmol/L的硫酸溶液,流速1.00mL/min,电导检测器检测。结果表明,4种离子的检出限分别为:Na+0.021 mg/L,K+0.020 mg/L、Mg2+0.015 mg/L,Ca2+0.100 mg/L,相对标准偏差在0.72%~3.92%之间,回收率为98.3%~103.1%。结论:该法操作简便、快速,准确,为测定其它中药中Na+、K+、Mg2+、Ca2+的含量提供了一种有效的方法。     

基于铽-沙拉沙星配合物的荧光增强测定人血清白蛋白

Tb3+和沙拉沙星(SRFX)反应生成二元配合物,发射Tb3+的特征荧光。人血清白蛋白(HSA)能够增强Tb3+-SRFX配合物的荧光强度,据此,建立了荧光法测定HSA的新方法。在最佳测定条件下,当HSA的浓度在0.50～90.0 mg/L时,Tb3+-SRFX-HSA体系荧光强度的增强和HSA的浓度有良好的线性关系,方法的检出限为0.13 mg/L。用该方法测定了人血清中HSA的含量,回收率在99.2%～99.6%之间。同时对荧光强度增强的机理进行了探讨。     

Determination of sialic acids in human serum by reversed-phase liquid chromatography with fluorimetric detection.

A simple, rapid and highly sensitive reversed-phase liquid chromatographic method has been developed for the determination of sialic acids in human serum. The sialic acids, released by hydrolysis of serum, are converted in borate buffer with malononitrile to highly fluorescent compounds. The reaction mixture is separated isocratically within 5 min using an octadecyl-bonded silica column and a mobile phase of methanol and ammonium acetate buffer (15:85, v/v; pH 5.5). Measurement of the fluorescence intensity of the reaction mixture at 434 nm with irradiation at 357 nm allowed determination of 30-1000 ng/ml of sialic acids with high reproducibility. The limit of detection was 2 ng/ml. Intra-day and inter-day coefficients of variation for assaying 300 ng/ml N-acetylneuraminic acid (NANA) were 1.5% (n = 9) and 2.6% (n = 7), respectively. The recoveries of NANA were 98.5-101.1% for serum. The method has been used for clinical determinations.     

Quantification of N-acetyl- and N-glycolylneuraminic acids by a stable isotope dilution assay using high-performance liquid chromatography-tandem mass spectrometry

The present report describes a method for the quantification of N-acetyl- and N-glycolylneuraminic acids without any derivatization, using their (13)C(3)-isotopologues as internal standards and a C(18) reversed-phase column modified by decylboronic acid which allows for the first time a complete chromatographic separation between the two analytes. The method is based on high-performance liquid chromatographic coupled with electrospray ion-trap mass spectrometry. The limit of quantification of the method is 0.1mg/L (2.0ng on column) for both analytes. The calibration curves are linear for both sialic acids over the range of 0.1-80mg/L (2.0-1600ng on column) with a correlation coefficient greater than 0.997. The proposed method was applied to the quantitative determination of sialic acids released from fetuin as a model of glycoproteins.     

液相色谱-串联质谱法检测人血浆及脂蛋白唾液酸的含量

建立了液相色谱-串联质谱(LC-MS/MS)检测人血浆脂蛋白唾液酸的方法,并比较了糖尿病患者与健康人血浆脂蛋白唾液酸的差异。采用pH=2的醋酸水解唾液酸,高速离心后采用优化的条件进行LC-MS/MS分析。结果表明:在负离子模式下,唾液酸的检出限和定量限分别为7.4和24.5 pg。唾液酸在2.5~80 ng/mL范围内呈良好的线性关系,相关系数R²大于0.998。糖尿病患者(平均年龄51.6岁)和健康人(平均年龄50.7岁)血浆中唾液酸的含量分别为(548.3±88.9)和(415.3±55.5)mg/L;两组实验人群中极低密度脂蛋白、低密度脂蛋白和高密度脂蛋白唾液酸的含量分别为(4.91±0.19)、(6.95±0.28)、(3.61±0.22)μg/mg和(2.90±0.27)、(7.03±0.04)、(2.40±0.09)μg/mg。糖尿病患者极低密度脂蛋白和高密度脂蛋白唾液酸含量显著高于同龄健康人水平(P<0.01)。该法可快速检测血浆中脂蛋白唾液酸含量,省时省力。     

高效液相色谱法同时测定血清和尿中厚朴酚与和厚朴酚

 建立了大鼠服用厚朴提取物后的血清中及尿中厚朴酚与和厚朴酚的高效液相色谱测定法。色谱柱填料为SpherisorbC18,流动相为甲醇-水-冰醋酸(体积比为70∶30∶1),UV检测波长为294nm,灵敏度0.005AUFS。样品用甲醇沉淀蛋白,上清液酸化后用乙酸乙酯-乙醚萃取,然后测定其中的药物浓度。血清和尿中的药物浓度与峰面积的线性关系良好,线性范围分别为0.05～2mg/L(厚朴酚)、0.025～1mg/L(和厚朴酚);精密度和重现性良好。血清中厚朴酚与和厚朴酚的平均加样回收率分别为95.6%(RSD=3.85%)和93.8%(RSD=3.95%),尿中分别为96.0%(RSD=3.83%)和94.9%(RSD=3.54%)。     

Assay of naproxen in rat serum by high-performance thin-layer chromatography/densitometry

A simple, sensitive, and reproducible high-performance thin-layer chromatographic method using densitometry is presented for the determination of naproxen in rat serum. Only 0.1 mL serum was used for extraction. Separations were performed on 10 x 10 cm plates coated with silica gel, with toluene-ethyl acetate-acetic acid (82 + 15 + 3) as the mobile phase. Benzophenone was used as the internal standard. Quantification was performed by densitometry at 260 nm. The response response for naproxen was linear (r = 0.992) over the range 2-100 mg/L. Method validation demonstrated good recoveries (92-96%), sensitivity (limit of quantitation, 1 mg/L), repeatability of sample application (4%), repeatability of the method (8%), and intermediate precision (5%). The procedure was applied to the quantitation of naproxen in rat serum.     

Capillary zone electrophoresis for determination of carbohydrate-deficient transferrin in human serum

Carbohydrate-deficient transferrin (CDT) is the most specific marker for diagnosis of chronic excessive alcohol consumption and includes the serum transferrin (Tf) isoforms with two or less sialic acid residues (di-, mono-, and asialo-Tf). To monitor serum CDT, we developed a capillary zone electrophoresis (CZE) method based on the dynamic capillary coating with diethylenetriamine (DETA). The separation was performed in a bare fused-silica capillary (50 microm ID, 57 cm in length), applying a voltage of 25 kV and a temperature of 40 degrees C. Using a 100 mmol/L borate buffer, pH 8.4 with 3 mmol/L DETA, the Tf isoforms (asialo- to pentasialo-Tf) were resolved within 16 min. Enzymatic cleavage of sialic acid residues with neuraminidase and immunosubtraction were used to identify CDT isoforms. The relative amount of CDT expressed as area % of disialo-Tf isoform related to the area of tetrasialo-Tf in 50 healthy donors (24 males and 26 females; aged 25-50 years) was 3.15 +/- 0.76% (mean +/- SD). The comparison between CDT values obtained by this CZE procedure and the "Axis-Shield %CDT" kit gave r = 0.644, p < 0.001 (n = 290). This easy to use and inexpensive CZE procedure could be an ideal tool to investigate CDT proteins for clinical or forensic purposes.     

Determination of selenium in blood serum by inductively coupled plasma atomic emission spectrometry with pneumatic nebulization

The possibility of determining selenium in blood serum using inductively coupled plasma emission spectrometry with conventional pneumatic nebulization was studied. A high-resolution spectrometer (SBW=6 pm) with laterally viewed ICP was employed. Analysis with conventional pneumatic nebulization could overcome laborious and demanding digestion, which is necessary for hydride generation. A pressure digestion with nitric acid at 160 degrees C was sufficient to decrease the carbon content in the serum sample to 5%-10% of its original value. Spectral interference of the CN band was observed and mathematically corrected. It was found that the carbon-induced selenium line emission enhancement occurred even under ICP optimized conditions. A method of determination was developed and applied to the analysis of blood serum. True limit of detection in real samples is 0.01-0.02 mg/L and the limit of quantification (RSD 10%) is 0.03-0.07 mg/L using Se I 196.090 nm line at an integration time of 10-2 s. The method was tested by analysis of porcine blood serum and the serum reference material Seronorm MI 0181.     

Gentamicin assay in human serum by solid-phase extraction and capillary electrophoresis

We describe the development of a capillary electrophoresis method for the determination of gentamicin C1, C1a, C2a, and C2 components in human serum. Using a weak cation-exchanger with 20 mM phosphate buffer, pH 7.4, 200 mM borate buffer, pH 9.0, and ammonia/methanol, solid-phase extraction (SPE) of gentamicin components from the human sera was performed. The extract was derivatized with 1,2-phthalic dicarboxaldehyde/mercaptoacetic acid reagent. The derivatives were separated with a background electrolyte comprising 60 mM 2-(N-cyclohexylamino)ethanesulfonic acid (CHES) buffer at pH 9.5 containing 31.6% m/v methanol, and quantified with UV-light absorption detection at 230 nm. The identity of the gentamicin components was confirmed by mass spectrometry. The SPE recovery of the gentamicin ranged from 78% to 93%. The calibration curves were linear from the concentration limit of quantitation (LOQ) to 30 mg/L for the gentamicin mixture. The LOQ for gentamicin C1 was 0.33 mg/L, for C2a 0.23 mg/L, C2 0.25 mg/L, C1a 0.27 mg/L and the concentration limit of detection (LOD) for C1 was 0.15 mg/L, C2a 0.11 mg/L, C2 0.12 mg/L, C1a 0.13 mg/L. Intra-assay relative standard deviation (RSD) values were for C1 (5%), C1a (7%), C2 (6.5%) and C2a (9%); inter-assay RSD values were for C1 (11%), C1a (13.3%), C2 (15%) and C2a (14%). The Pearson's correlation between capillary electrophoresis and immunoassay revealed a linear relationship between these two techniques with r = 0.9. This method for determination of gentamicin C1, C1a, C2a, and C2 in human serum can thus be used in the entire therapeutic concentrations range of gentamicin.